EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Access to symptom screening and severe symptom risk among cancer patients with major mental illness

Laura E Davis iD, Rinku Sutradhar, Michaela A Bourque, Antoine Eskander, Christopher W Noel, Elie Isenberg-Grzeda, Simone N Vigod, Natalie Coburn, Julie Deleemans, James M Bolton, Wing C Chan, Julie Hallet und 1 weitere

Psycho-Oncology · 2023

DOI: 10.1002/pon.6204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2023. Verfasst von Laura E Davis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Neoplasms, Mental Disorders, Symptom Assessment, Health Services Accessibility. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hanna Research Award, Odette Cancer Centre, Sunnybrook Health Sciences Centre Alternate Funding Plan Innovation grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cancer symptom screening has the potential to improve cancer outcomes, including reducing symptom burden among patients with major mental illness (MMI). We determined rates of symptom screening with the Edmonton Symptom Assessment System (ESAS‐r) and risk of severe symptoms in cancer patients with MMI.

Methods

This retrospective cohort study used linked administrative health databases of adults diagnosed with cancer between 2007 and 2020. An MMI was measured in the 5 years prior to cancer diagnosis and categorized as inpatient, outpatient, or no MMI. Outcomes were defined as time to first ESAS‐r screening and time to first moderate‐to‐severe symptom score. Cause‐specific and Fine and Gray competing events models were used for both outcomes, controlling for age, sex, rural residence, year of diagnosis and cancer site.

Results

Of 389,870 cancer patients, 4049 (1.0%) had an inpatient MMI and 9775 (2.5%) had an outpatient MMI. Individuals with inpatient MMI were least likely to complete an ESAS‐r (67.5%) compared to those with outpatient MMI (72.3%) and without MMI (74.8%). Compared to those without MMI, individuals with an inpatient or outpatient MMI had a lower incidence of symptom screening records after accounting for the competing risk of death (subdistribution Hazard Ratio 0.77 (95% CI 0.74–0.80) and 0.88 (95% CI 0.86–0.90) respectively). Individuals with inpatient and outpatient MMI status consistently had a significantly higher risk of reporting high symptom scores across all symptoms.

Conclusions

Understanding the disparity in ESAS‐r screening and management for cancer patients with MMI is a vital step toward providing equitable cancer care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMental DisordersSymptom AssessmentHealth Services AccessibilityMass ScreeningHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAdultSeverity of Illness Index

Stichwörter der Autor:innen

cancerhealth inequalitiesmental disordersneoplasmsoncologypatient-reported outcome measurespsycho-oncology

Autor:innen und Institutionen

  • Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
  • ICES, Toronto, Ontario, Canada.
  • Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • School of Nursing, Queen's University, Kingston, Ontario, Canada.
  • Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Laura E Davis

Förderung

  • Hanna Research Award
  • Odette Cancer Centre
  • Sunnybrook Health Sciences Centre Alternate Funding Plan Innovation grant
  • Canadian Cancer Society Emerging Scholar
  • Ontario Ministry of Health and Long-Term Care

Zitieren

APA

Davis, L. E., Sutradhar, R., Bourque, M. A., Eskander, A., Noel, C. W., Isenberg-Grzeda, E., Vigod, S. N., Coburn, N., Deleemans, J., Bolton, J. M., Chan, W. C., Hallet, J., & Mahar, A. L. (2023). Access to symptom screening and severe symptom risk among cancer patients with major mental illness. Psycho-Oncology. https://doi.org/10.1002/pon.6204

Vancouver

Davis LE, Sutradhar R, Bourque MA, Eskander A, Noel CW, Isenberg-Grzeda E, et al. Access to symptom screening and severe symptom risk among cancer patients with major mental illness. Psycho-Oncology. 2023. doi:10.1002/pon.6204

BibTeX
@article{Davis2023,
  author = {Davis, Laura E and Sutradhar, Rinku and Bourque, Michaela A and Eskander, Antoine and Noel, Christopher W and Isenberg-Grzeda, Elie and Vigod, Simone N and Coburn, Natalie and Deleemans, Julie and Bolton, James M and Chan, Wing C and Hallet, Julie and Mahar, Alyson L},
  title = {Access to symptom screening and severe symptom risk among cancer patients with major mental illness},
  journal = {Psycho-Oncology},
  year = {2023},
  doi = {10.1002/pon.6204}
}
Kostenlos starten →